Advances in infectious disease vaccine adjuvants
J Fan, S Jin, L Gilmartin, I Toth, WM Hussein… - Vaccines, 2022 - mdpi.com
Vaccines are one of the most significant medical interventions in the fight against infectious
diseases. Since their discovery by Edward Jenner in 1796, vaccines have reduced the …
diseases. Since their discovery by Edward Jenner in 1796, vaccines have reduced the …
Recent advances in intranasal liposomes for drug, gene, and vaccine delivery
Liposomes are safe, biocompatible, and biodegradable spherical nanosized vesicles
produced from cholesterol and phospholipids. Recently, liposomes have been widely …
produced from cholesterol and phospholipids. Recently, liposomes have been widely …
[HTML][HTML] Liposome-polymer complex for drug delivery system and vaccine stabilization
Liposomes have been used extensively as micro-and nanocarriers for hydrophobic or
hydrophilic molecules. However, conventional liposomes are biodegradable and quickly …
hydrophilic molecules. However, conventional liposomes are biodegradable and quickly …
Pelvic Inflammatory Disease Due to Neisseria gonorrhoeae and Chlamydia trachomatis: Immune Evasion Mechanisms and Pathogenic Disease Pathways
T Darville - The Journal of infectious diseases, 2021 - academic.oup.com
Pelvic inflammatory disease (PID) results from ascension of sexually transmitted pathogens
from the lower genital tract to the uterus and/or fallopian tubes in women, with potential …
from the lower genital tract to the uterus and/or fallopian tubes in women, with potential …
Update on the epidemiology, screening, and management of Chlamydia trachomatis infection
JS Hocking, WM Geisler, FYS Kong - Infectious Disease Clinics, 2023 - id.theclinics.com
Chlamydia trachomatis infection (“chlamydia”) is the most commonly diagnosed bacterial
sexually transmitted infection (STI) globally with an estimated 130 million new cases each …
sexually transmitted infection (STI) globally with an estimated 130 million new cases each …
[HTML][HTML] Swine as biomedical animal model for T-cell research—Success and potential for transmittable and non-transmittable human diseases
T Käser - Molecular immunology, 2021 - Elsevier
Swine is biologically one of the most relevant large animal models for biomedical research.
With its use as food animal that can be exploited as a free cell and tissue source for research …
With its use as food animal that can be exploited as a free cell and tissue source for research …
[HTML][HTML] Chlamydia trachomatis: Cell biology, immunology and vaccination
Chlamydia trachomatis is the causative agent of a highly prevalent sexually transmitted
bacterial disease and is associated with a number of severe disease complications. Current …
bacterial disease and is associated with a number of severe disease complications. Current …
Vaccines, adjuvants and key factors for mucosal immune response
VA Correa, AI Portilho, E De Gaspari - Immunology, 2022 - Wiley Online Library
Vaccines are the most effective tool to control infectious diseases, which provoke significant
morbidity and mortality rates. Most vaccines are administered through the parenteral route …
morbidity and mortality rates. Most vaccines are administered through the parenteral route …
Prevention strategies for sexually transmitted infections, HIV, and viral hepatitis in Europe
D Gökengin, T Noori, A Alemany… - The Lancet Regional …, 2023 - thelancet.com
The current prevention efforts for STIs, HIV and viral hepatitis in the WHO European Region,
especially in the Central and Eastern subregions, are hindered by healthcare disparities …
especially in the Central and Eastern subregions, are hindered by healthcare disparities …
Protection against SARS-CoV-2 transmission by a parenteral prime—Intranasal boost vaccine strategy
Background Licensed vaccines against SARS-CoV-2 effectively protect against severe
disease, but display incomplete protection against virus transmission. Mucosal vaccines …
disease, but display incomplete protection against virus transmission. Mucosal vaccines …